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Department of Biomedical Engineering, Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VirginiaABSTRACT Cardiac excitation-contraction coupling is a highly coordinated process that is controlled by protein kinase
signaling pathways, including Ca2þ/calmodulin-dependent protein kinase II (CaMKII) and protein kinase A (PKA). Increased
CaMKII expression and activity (as occurs during heart failure) destabilizes EC coupling and may lead to sudden cardiac death.
To better understand mechanisms of cardiac CaMKII function, we integrated dynamic CaMKII-dependent regulation of key Ca2þ
handling targets with previously validated models of cardiac EC coupling, Ca2þ/calmodulin-dependent activation of CaMKII, and
b-adrenergic activation of PKA. Model predictions are validated against CaMKII-overexpression data from rabbit ventricular
myocytes. The model demonstrates how overall changes to Ca2þ handling during CaMKII overexpression are explained by
interactions between individual CaMKII substrates. CaMKII and PKA activities during b-adrenergic stimulation may synergisti-
cally facilitate inotropic responses and contribute to a CaMKII-Ca2þ-CaMKII feedback loop. CaMKII regulated early frequency-
dependent acceleration of relaxation and EC coupling gain (which was highly sarcoplasmic reticulum Ca2þ load-dependent).
Additionally, the model identifies CaMKII-dependent ryanodine receptor hyperphosphorylation as a proarrhythmogenic trigger.
In summary, we developed a detailed computational model of CaMKII and PKA signaling in cardiac myocytes that provides
unique insights into their regulation of normal and pathological Ca2þ handling.INTRODUCTIONCa2þ/Calmodulin-dependent protein kinase II (CaMKII) is
a key regulator of cardiac excitation-contraction coupling
(ECC) that has emerged as a potential therapeutic target
for heart failure and arrhythmia (1). The activation of
CaMKII by Ca2þ-bound calmodulin (CaM) affords it the
ability to decode both the frequency and location of Ca2þ
signals (2,3). CaMKII expression is increased in failing
human myocardium (4) and hyperactivity has been linked
to the induction of hypertrophy and arrhythmias (5,6).
Chronic (7) and acute (8) CaMKII overexpression studies
have demonstrated that this kinase regulates myocyte
Ca2þ handling, though the specific mechanisms by which
these changes occur are unclear. Both CaMKII and protein
kinase A (PKA) phosphorylate a number of Ca2þ handling
targets with similar functional consequences (including
L-type Ca2þ channels (LCCs), ryanodine receptors
(RyRs), and phospholamban (PLB)), though how these
two pathways communicate with one another remains unre-
solved.
To examine how the known molecular mechanisms of
CaMKII and PKA interact to coordinate ECC and trigger
arrhythmia, we developed an integrated computational
model of CaMKII and PKA signaling in the rabbit ventric-
ular myocyte. The model includes dynamic phosphorylation
of LCCs, RyRs, and PLB by CaMKII and PKA, as well as
functional regulation of additional targets distinct to each
kinase. These interactions were integrated with previously
validated models of Ca2þ/CaM-dependent activation ofSubmitted December 18, 2009, and accepted for publication August 4, 2010.
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0006-3495/10/10/2038/10 $2.00CaMKII (3), b-adrenergic activation of PKA (9), and
cardiac ECC in the rabbit ventricular myocyte (10). With
this framework, we examined a number of unanswered
questions in cardiac CaMKII/PKA signaling:
How do the individual actions of CaMKII substrates
work together to modulate overall Ca2þ handling?
Can CaMKII enhance its own activity via a CaMKII-
Ca2þ-CaMKII positive feedback loop?
Does b-adrenergic stimulation increase dyadic CaMKII
activity via enhanced Ca2þ fluxes and, if so, does
this additional activity contribute to inotropic
responses?
Finally, under what conditions can CaMKII activity lead
to the development of cellular arrhythmias?
The model shows how synergy between individual
CaMKII activities modulates overall myocyte Ca2þ
handling, that CaMKII-PKA synergy may contribute to
full adrenergic responses, and that CaMKII-dependent
modulation of RyR function can trigger arrhythmias.METHODS
Dynamic CaMKII and PKA-dependent phosphorylation were modeled
using mass action and Michaelis-Menten kinetics (11). PKA phosphoryla-
tion modules are essentially the same as those in our previous model (9).
Model parameters were obtained from the biochemical literature or esti-
mated by nonlinear least-squares fitting to cellular data as described in
the Supporting Material.
Structurally, the model consists of three main modules:
1. Activation of CaMKII and phosphorylation of ECC targets,
2. b-adrenergic activation of PKA and phosphorylation, anddoi: 10.1016/j.bpj.2010.08.016
CaMKII Regulation of Ca Handling 20393. The cardiac ECC model of the rabbit ventricular myocyte from Shannon
et al. (10), including detailed cellular electrophysiology, Ca2þ diffusion
between distinct compartments, and graded Ca2þ release from the sarco-
plasmic reticulum (SR), in which regulation by modules 1 and 2 was
included.
To model the effects of CaMKII and PKA on LCC modal gating (12,13),
we adapted an established Markovian formulation for the LCC (14) (see
Fig. S1 in the Supporting Material). All simulations were performed in
MATLAB (The MathWorks, Natick, MA) using the stiff ODE solver
ode15s.FIGURE 1 Model schematic. CaMKII is activated by Ca2þ/CaM binding
in the dyadic cleft, subsarcolemma, and cytosolic compartments. Active
CaMKII phosphorylates LCCs, RyRs, and PLB. During overexpression
simulations, CaMKII-dependent alterations to INa(f,L) and Ito were included.
PKA phosphorylates LCCs, RyRs, PLB, Inhibitor-1, troponin I (TnI), IKs,
and cystic fibrosis transmembrane conductance regulator (CFTR) and
phosphatases 1 and 2A oppose phosphorylation by either kinase.Phosphorylation modules
LCC
CaMKII phosphorylation rapidly facilitates LCC current (ICa), seen as
a stepwise increase in peak ICa with repeated stimulation (Fig. S2)
(13,15,16). CaMKII alters LCC gating by increasing the fraction of chan-
nels operating in mode 2, characterized by high Po (13). Facilitation is
enhanced during CaMKII overexpression (8) and eliminated during
CaMKII knockout. Additional properties of CaMKII-dependent changes
to ICa are provided in Fig. S3. PKA increases LCC Po and availability
via phosphorylation of a1C and b2a sites, respectively (9).
RyR
CaMKII phosphorylation of RyRs (mainly at Ser2815 in rabbit) has been re-
ported to increase channel Ca2þ sensitivity, opening probability, and leak
(17–20). Basal phosphorylation and biphasic dephosphorylation by PP1
and PP2A at Ser2815 were included by fitting to experimental data of
increasing phosphatase inhibition by okadaic acid (Fig. S4). PKA also
enhances RyR Ca2þ sensitivity during adrenergic stimulation.
PLB, INa, and Ito
CaMKII phosphorylation of PLB (at Thr17) may be <5% in normal condi-
tions (21). In our model, cytosolic CaMKII is not sufficient to regulate PLB
(3). To achieve appropriate frequency-dependent Thr17 phosphorylation
(22), we modeled this using dyadic cleft CaMKII signals (see the Support-
ing Material). PLB phosphorylation by both CaMKII and PKA (at Ser16)
relieves SERCA inhibition and roughly doubles the pump’s Ca2þ sensitivity
(22–24). Also, PKA activation of inhibitor-1 blocks PP1 near PLB, thereby
increasing Thr17 phosphorylation during adrenergic stimulation (Fig. S6).
Lastly, CaMKII overexpression in rabbit myocytes delays INa recovery
from inactivation, enhances INa,L magnitude (Fig. S7 A), hastens Ito
recovery from inactivation (Fig. S8 A), and increases Ito magnitude
(Fig. S8 B) (25,26).
Others
PKA-specific regulation of the slow delayed rectifier Kþ current (IKs),
troponin I, and the cystic fibrosis transmembrane conductance regulator
Cl current were included. An overall model schematic is provided in
Fig. 1, with further details of model equations, parameters, and justification
provided in Table S1 in the Supporting Material.RESULTS
Frequency-dependence of CaMKII-mediated
phosphorylation
Phosphorylation of all CaMKII substrates is predicted to
exhibit positive frequency dependence, though phosphory-
lation levels and kinetics are quantitatively quite distinct
(Fig. 2). The model predicts highly dynamic CaMKIIactivity and oscillatory phosphorylation kinetics, which
adapt to changes in pacing with distinct kinetics
(Fig. 2 A). LCCs exhibit moderate to high phosphorylation
during control scenarios (Fig. 2 B). LCC phosphorylation
reaches steady state within ~5 beats when the myocyte is
paced from rest, consistent with ICa facilitation kinetics in
Fig. S2. With CaMKII overexpression (CaMKII-OE, 6
increase), LCC phosphorylation saturates at lower frequen-
cies. In contrast, RyR and PLB phosphorylation exhibit
moderate positive frequency-dependence in control condi-
tions. RyR phosphorylation increases from ~15% at rest
to ~29% at 3 Hz pacing (Fig. 2 C), while PLB phosphoryla-
tion is <10% at all frequencies (Fig. 2 D). During CaMKII-
OE, however, RyR and PLB phosphorylation is amplified.
The predicted increase in RyR phosphorylation with
CaMKII-OE at 1 Hz is similar to that seen experimentally
(8) (Fig. S5). Together, these predictions indicate that the
frequency-dependence of CaMKII substrates may vary
considerably even when regulated by the same Ca2þ and
CaMKII signals.CaMKII-dependent changes to Ca2þ handling
and electrophysiology
At 1 Hz pacing, Ca2þ transient magnitude (D[Ca2þ]i) was
402 nM in control simulations, though CaMKII-OE slightly
reduced D[Ca2þ]i to 366 nM (~91% of control) (Fig. 3 A).
Experimental Ca2þ transients showed a similar, though
statistically insignificant, decrease in D[Ca2þ]i with acute
CaMKII-OE (725 8% of control) (Fig. 3 C, left columns).
With CaMKII-KO, the model predicted a decrease in
D[Ca2þ]i to 281 nM (Fig. 3 A, dashed line). BothBiophysical Journal 99(7) 2038–2047
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FIGURE 2 Time-course and frequency-depen-
dence of CaMKII phosphorylation. (A) Dyadic
CaMKII activity and phosphorylation profiles
during a CaMKII-OE simulation at low (0.5 Hz)
and higher (2 Hz) frequency pacing. Note the
differences between phosphorylation kinetics,
which are very fast at the LCC, slower at the
RyR, and very slow at PLB. (B–D) Time-averaged
steady-state phosphorylation levels at (B) LCC, (C)
RyR, and (D) PLB are frequency-dependent and
sensitive to the amount of active CaMKII (control
versus OE).
2040 Soltis and SaucermanCaMKII-OE and CaMKII-KO reduced action potential
duration (APD), consistent with the experimentally mea-
sured APD for CaMKII-OE but somewhat overestimating
the amount of APD shortening due to CaMKII inhibition
in rabbit myocytes (26) (Fig. 3 B).
Total SR Ca2þ content ([Ca2þ]SRT) was reduced in
response to CaMKII-OE in both model predictions
(~23%) and published experiments (~405 15%) (Fig. 3 C,
right). Additionally, fractional SR Ca2þ release was
enhanced in both model predictions (127% of control) and
experimental data (158 5 23% of control). Absolute frac-
tional release values at 1 Hz pacing are also in agreementA
B
C
D F
E
Biophysical Journal 99(7) 2038–2047with experimental data (Fig. 3 D). The model exhibits the
positive frequency dependence of D[Ca2þ]i (Fig. 3 E)
and [Ca2þ]SRT (Fig. 3 F) observed in rabbit ventricular
myocytes (though SR content changes only slightly beyond
1 Hz) (10). During CaMKII-OE, however, D[Ca2þ]i and
[Ca2þ]SRT progressively deviate from control values. At
low frequencies (0.25 and 0.5 Hz), D[Ca2þ]i slightly rises
in response to CaMKII-OE, though the relationship flips
at frequencies R1 Hz. These predictions can be explained
by the quantitative differences between phosphorylation
levels at low and high frequencies (Fig. 2). Also, CaMKII-
KO reduced D[Ca2þ]i despite a higher SR Ca
2þ content,FIGURE 3 Effects of CaMKII onmyocyte Ca2þ-
handling and electrophysiology. (A) At 1Hzpacing,
both CaMKII-OE and CaMKII-KO depress
D[Ca2þ]i compared to control. Diastolic [Ca
2þ]i
for control, OE, and KO simulations was 92.6,
69.1, and 95.8 nM, respectively. (B) APD is shorter
during CaMKII-OE (194 ms) and CaMKII-
KO (199 ms) simulations compared to control
(213 ms). (C) Comparison of D[Ca2þ]i and
[Ca2þ]SRT during CaMKII-OE in model (gray
bars) and experimental data (black bars, data
from (8), n.s. ¼ not significant). (D) CaMKII over-
expression increases fractional release of Ca2þ
from the SR (data from (8)). (E and F) Frequency-
dependence of D[Ca2þ]i and [Ca
2þ]SRT. (E) Model
predicts slightly smallerD[Ca2þ]i at larger frequen-
cies (R1 Hz) with CaMKII-OE and depressed
D[Ca2þ]i at all frequencies during CaMKII-KO.
(F) CaMKII-OE dramatically decreases SR Ca2þ
across all frequencies, while CaMKII-KO allows
greater SR filling at higher frequencies.
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CaMKII Regulation of Ca Handling 2041suggesting the potential role of CaMKII in the positive
frequency dependence of D[Ca2þ]i in normal myocytes.
As additional validations, postrest decay was enhanced
by CaMKII-OE (as seen in similar experiments (8),
Fig. S10) and [Na]i was slightly greater at all tested frequen-
cies during CaMKII-OE (though larger increases have been
observed experimentally (25), perhaps due to additional
mechanisms; see Fig. S7, B and C). The included effects
on INa(f,L) and Ito in combination contributed to slightly
larger [Ca2þ]i transients during pacing (Fig. S9). These
results demonstrate that our model is capable of predicting
key changes to myocyte Ca2þ handling and electro-
physiology that have been shown experimentally with
CaMKII-OE.0
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FIGURE 4 CaMKII-dependent enhancement of FDAR via LCC phos-
phorylation and effects on ECC gain. (A) Time course of D[Ca2þ]i t50
values in response to increased pacing frequency (0.25–1 Hz at 4 s). Control
simulations showed rapid FDAR adaptation, though CaMKII-KO slowed
early FDAR. (B) ECC gain assessed by voltage-clamp (80 mV holding
potential, 0 mV test for 200 ms, 500 ms basic cycle length) until steady state
was reached. ECC gain is reported as peak steady-state JRyR over peak
steady-state JLCC. ECC gain was reduced by both CaMKII-OE and
CaMKII-KO simulations, though SR loads varied considerably between
conditions. The last two bars are from simulations with SR content fixed
to the control value. In this case, CaMKII-OE dramatically increased
ECC gain at 0 mV (from 7.2 to 25), while CaMKII-KO decreased ECC
gain (to 1.7) compared to control.Role of CaMKII in FDAR and ECC gain
CaMKII is believed to participate in frequency-dependent
acceleration of relaxation (FDAR), though the mechanisms
for such control are unclear and may not involve PLB
(21,27,28) or SERCA (29). Between 0.5 and 3 Hz, we found
that steady-state FDAR (quantified as the t50 of D[Ca
2þ]i
relaxation) was only modestly CaMKII-dependent
(CaMKII-OE and KO made the slope of FDAR slightly
more and less negative, respectively; see Fig. S11). As an
additional test for CaMKII-dependence, we monitored the
time course of FDAR development during a rapid switch
from 0.25 to 1 Hz pacing (see Fig. 4 A and Fig. S12). As
expected, our control model rapidly adapted to faster
pacing. However, the early phase of FDAR was blunted in
CaMKII-KO simulations, suggesting CaMKII contributes
to the early phase of FDAR. Additional simulations were
performed with CaMKII-dependent LCC or RyR phosphor-
ylation eliminated (Fig. S12, right panels), showing that
LCC phosphorylation is necessary for this early phase.
Steady-state FDAR was enhanced by elimination of RyR
phosphorylation but reduced by elimination of LCC phos-
phorylation (Fig. S12 F). Thus, overall FDAR appears to
depend on a balance of LCC and RyR phosphorylation by
CaMKII.
ECC gain, defined by the ratio of peak RyR Ca2þ flux to
peak trigger LCC Ca2þ flux, is a central element of ECC. To
determine whether CaMKII modulates ECC gain, we paced
the model myocyte under voltage-clamp to steady state
(80 mV holding potential, 0 mV test, 2 Hz) and quantified
peak LCC and RyR fluxes (JLCC and JRyR, respectively).
Surprisingly, the control model exhibited the highest ECC
gain, despite increased ICa amplitude and RyR Po in the
CaMKII-OE model (Fig. 4 B, left columns). However,
[Ca2þ]SRT was not equal across the three tested conditions
(see labels in Fig. 4 B). To eliminate the influence of SR
loading on these results, we ran additional simulations for
CaMKII-OE and KO at fixed [Ca2þ]SRT (1.74 mM, the
control level) and found that, in these conditions, CaMKII-
OE dramatically enhanced ECC gain, while gain in the KOcondition was depressed substantially (Fig. 4 B, right
columns).Comparative analysis of CaMKII target effects
We used the model to further examine how individual
CaMKII substrates produce the combined effects discussed
earlier. Individual substrate contributions to the overall
CaMKII-OE response at 1 Hz were isolated by overexpress-
ing CaMKII and allowing CaMKII-dependent phosphoryla-
tion of a single substrate; the results are summarized in
Table 1. CaMKII enhancement of ICa in isolation mainly
enhanced Ca2þ transients (~31%). On the other hand, RyR
effects substantially decreased D[Ca2þ]i (~24%) andBiophysical Journal 99(7) 2038–2047
TABLE 1 Comparative analysis of individual CaMKII interactions
Control CaMKII overexpression KO
Parameter All targets All targets LCC effect only RyR effect only PLB effect only Ito/INa effects only All targets
D[Ca]i (nM) 402 365 525 306 414 431 281
[Ca]SRT (mM) 1.87 1.44 1.91 1.44 1.88 1.86 1.93
Fractional release 0.34 0.43 0.39 0.39 0.35 0.35 0.26
APD90 (ms) 213 194 220 213 210 190 199
Effects of overexpressing CaMKII for individual targets (LCC, RyR, PLB, and Ito/INa) on overall D[Ca
2þ]i, [Ca
2þ]SRT, fractional release, and APD during
1 Hz pacing. RyR phosphorylation is the only effect responsible for decreasing D[Ca2þ]i and [Ca
2þ]SRT, while no one effect dominates the overall increase in
fractional release. The net effect of Ito and INa regulation mostly contributes to APD shortening. The effects of global CaMKII inhibition are provided in the
last column.
2042 Soltis and Saucerman[Ca2þ]SRT (~23%), while PLB phosphorylation alone
modestly affected all parameters, perhaps due to the low
quantitative phosphorylation levels at PLB-Thr17. Net Ito
and INa effects increased D[Ca
2þ]i (~7%) and decreased
APD (~12%). Thus, the overall decreased D[Ca2þ]i and
[Ca2þ]SRT seen with CaMKII-OE may be primarily ex-
plained by increased phosphorylation of RyRs, although
LCC phosphorylation largely compensates for the decreased
D[Ca2þ]i and, to a lesser extent, [Ca
2þ]SRT. Interestingly, all
targets positively influenced fractional release to a small
extent, but the overall 27% increase is only seen when
combining all effects. This indicates that global changes
to ECC are dictated by the relative strengths of several
CaMKII interactions working in synergy. Results from 1 Hz
CaMKII-KO simulations are also shown for comparison.CaMKII-Ca2þ-CaMKII positive feedback during
normal ECC and b-adrenergic stimulation
We hypothesized that positive feedback from CaMKII to
Ca2þ to CaMKII (via enhanced Ca2þ fluxes) may be a prom-A B
C
D
Biophysical Journal 99(7) 2038–2047inent feedback loop. To test this in the model, we analyzed
dyadic CaMKII activity during control and CaMKII-OE
simulations (Fig. 5 A). At 2 Hz pacing, CaMKII-OE
increased average CaMKII activity (59.5% vs. 53.8% for
control) and t50% (222 vs. 210 ms). To test whether this
increased activity is the result of feedback as opposed to
the fact that overall CaMKII availability is enhanced,
additional CaMKII-OE simulations were run with phos-
phorylation levels at each CaMKII substrate fixed to their
steady-state diastolic levels (CaMKII-OE þ Target KO).
In this case, CaMKII average activity and t50% were
57.5% and 216 ms, respectively, suggesting that overexpres-
sion of CaMKII alone enhances activity, though the subse-
quent CaMKII-dependent enhancement of Ca2þ fluxes
feeds back to increase activity further.
We next evaluated how much each individual CaMKII
substrate contributed to overall CaMKII-Ca2þ-CaMKII
feedback. Interestingly, most CaMKII substrates contrib-
uted to the overall feedback (except Ito and INa), with RyR
phosphorylation producing the strongest individual effect.
However, all targets working together produced theFIGURE 5 CaMKII-Ca2þ-CaMKII feedback
and b-adrenergic response. (A) Single 2 Hz dyadic
cleft CaMKII transients from control, CaMKII-
OE, and CaMKII-OE þ Target KO (i.e., all target
phosphorylation levels fixed to control values)
simulations. Feedback is evident because t50 and
average CaMKII activity increase with overexpres-
sion alone, though CaMKII-OE with all functional
targets present increases these parameters further.
(B and C) Analysis of individual target contribu-
tions to enhanced CaMKII activity. ISO also
increased t50 and average activity of CaMKII. (D)
ISO substantially increases [Ca2þ]i transients
during 2 Hz pacing, though the full response
depends on synergy between CaMKII and PKA
substrates.
AB
CaMKII Regulation of Ca Handling 2043strongest response (Fig. 5, B and C, middle columns).
Increases in Ca2þ fluxes by other kinases may enhance
CaMKII activity in a similar manner. To test whether
b-adrenergic signaling through PKA enhances CaMKII
activity, we ran additional simulations with 1 mM isoproter-
enol (ISO) (see Fig. S13 for sample outputs from the
b-adrenergic model). Through PKA enhancement of Ca2þ
fluxes, CaMKII activity and t50% were enhanced, which
was further potentiated by CaMKII-OE (Fig. 5, B and C,
right columns).
We next tested whether this feedback loop contributes to
the increased Ca2þ transients during b-adrenergic stimula-
tion. As expected for the control model, ISO significantly
enhanced Ca2þ transients (~2.6-fold) (Fig. 5 D). But when
CaMKII was eliminated (CaMKII-KO), the ISO response
was partially diminished. We found that the change in
Ca2þ transients from CaMKII-KO to ‘‘control þ ISO’’
models (D[Ca2þ]i of 1181 nM) was larger than the sum of
the Ca2þ transient increases from CaMKII-KO to control
(D[Ca2þ]i ¼ 239 nM) and ‘‘CaMKII-KO þ ISO’’
(D[Ca2þ]i ¼ 860 nM), indicating synergy between PKA
and CaMKII in the overall b-adrenergic response. Thus,
this feedback loop appears to be both stimulated by and
partially contribute to the response of Ca2þ transients to
b-adrenergic stimulation.FIGURE 6 CaMKII overexpression induces DADs. (A and B) After
abrupt removal of a >60 s, 2 Hz stimulus (see arrows labeled stimuli),
DADs are observed in CaMKII-OE simulations with ISO. Note that
CaMKII-OE also reduces D[Ca2þ]i in response to ISO (A). SR Ca
2þ release
during each DAD was assessed by integrating total RyR flux during after-
depolarizations. The smaller 65-mM release event produced a subthreshold
DAD, while the larger 86-mM release induced a full AP (B). Both values fall
on either side of our model’s threshold of ~70 mM for generation of a full
AP, which is quantitatively consistent with an experimentally measured
value of ~64 mM (31).Arrhythmogenesis
Abnormal CaMKII signaling is suggested to be proarrhyth-
mogenic (5,6,30), so the model was used to test whether
the included mechanisms could predict such scenarios.
The model was stimulated to steady state with 2 Hz pacing
and spontaneous activity was monitored after abrupt
stimulus removal. Control simulations with 1 mM ISO
show [Ca2þ]i (Fig. 6 A) and membrane potential (Fig. 6
B) profiles that return to rest after stimulus removal. With
CaMKII-OE, however, peak [Ca2þ]i is reduced by ~36%
and delayed after-depolarizations (DADs) are seen after
stimulus removal. Typically, DADs occur after repolariza-
tion of the membrane has completed and are triggered by
aberrant release of Ca2þ from the SR (30). In the model,
enhanced RyR Ca2þ sensitivity together with rising
[Ca2þ]SR increases RyR leak. Initially, RyR leak slowly
increases dyadic [Ca2þ] and begins to decrease [Ca2þ]SR
once Jleak > JSERCA. But once dyadic [Ca
2þ] rises
sufficiently, it triggers RyR opening, causing sharp increases
in dyadic Ca2þ and then subsarcolemmal [Ca2þ]. Increased
subsarcolemmal [Ca2þ] stimulates inward Naþ/Ca2þ
exchange (INCX), resulting in membrane depolarization
(DADs).
To validate the predicted relationship between SR Ca2þ
release and DAD generation, we induced graded SR Ca2þ
release events after 2-Hz pacing during CaMKII-OE þ ISO
and measured subsequent changes in membrane potential.
We found that our model has a full DAD threshold of~70 mmol/L cytosol Ca2þ, which is quantitatively consistent
with an experimentally measured threshold of ~64 mmol/L
cytosol (31) (see Fig. S14 for details of this analysis).
Interestingly, CaMKII-OEþ ISO produced DADs only at
frequenciesR2 Hz. During CaMKII-OE alone at 2 Hz, dia-
stolic RyR leak (Jleak) increased from ~5 to 12 mmol/L
cytosol/s, though [Ca2þ]SRT was insufficient for sponta-
neous release (Fig. 3 F). However, the addition of ISO
during CaMKII-OE increased [Ca2þ]SRT. This effect,
coupled with CaMKII-induced increases in RyR Ca2þ sensi-
tivity and Jleak (~15 mM/s in this case), induced spontaneous
RyR opening that triggered the predicted DADs. At 3 Hz,
increased RyR phosphorylation further lowered the
threshold for SR release, triggering a subthreshold DAD
even in the absence of ISO (data not shown). With ISO alone
in the control model, Jleak increased only slightly (from ~5
to ~7 mM/s) and no DADs were produced. If CaMKII
phosphorylation of RyRs is specifically eliminated during
CaMKII-OE þ ISO, no DADs are seen (Fig. S15).Biophysical Journal 99(7) 2038–2047
2044 Soltis and SaucermanIn contrast, if PKA-mediated phosphorylation of RyRs is
eliminated, DADs are still observed.DISCUSSION
We incorporated CaMKII and PKA-dependent regulation of
cardiac myocyte Ca2þ handling into a computational model
of the rabbit ventricular myocyte. From this study, we were
able to obtain new mechanistic insights regarding how
these kinases coordinate control of excitation-contraction
coupling. We also explored scenarios where CaMKII-
induced dysregulation of ECC promoted cellular arrhyth-
mias.
Several groups have developed models of CaMKII-
dependent regulation of ECC. Hund and Rudy (32) found
that ECC gain increases with frequency due to CaMKII,
leading to a positive Ca2þ transient-frequency relationship.
Grandi et al. (33) showed that static CaMKII-dependent
modulations to ICa, Ito, and INa have distinct functional
consequences on APD, though their collective activity
promotes AP shortening. Hund et al. (34) showed that CaM-
KII hyperactivity and effects on INa contribute to abnormal
Ca2þ homeostasis and AP upstroke velocity in infarct
border zones. Hashambhoy et al. (35) developed a detailed,
stochastic model of CaMKII-LCC interactions, finding that
CaMKII-induced redistribution of LCC gating modes
explains ICa facilitation.
Our model builds on this past work, providing a number
of methodological advances that led to new mechanistic
insights. Methodological advances include:
1. Development of biochemically detailed phosphorylation
models of LCCs, RyRs, and PLB regulated by
Ca2þ/CaM-activated CaMKII.
2. Integration of these phosphorylation modules with well-
validated models of b-adrenergic signaling and ECC.
3. Successful validation of our model against a number of
experimental readouts, including CaMKII effects on
i. LCC facilitation and recovery from inactivation;
ii. RyR and PLB phosphorylation;
iii. SR Ca2þ content;
iv. fractional release;
v. Ca2þ transient amplitude;
vi. APD;
vii. FDAR; and
viii. postrest decay.
Using this quantitative framework, model analysis pro-
vided a number of new mechanistic insights, showing how:
1. CaMKII substrates are differentially phosphorylated in
a context-dependent manner.
2. Interactions among CaMKII substrates determine overall
consequences to myocyte Ca2þ handling and APD.
3. CaMKII participates in a CaMKII-Ca2þ-CaMKII posi-
tive feedback loop that is potentiated by enhanced
Ca2þ fluxes through PKA signaling.Biophysical Journal 99(7) 2038–20474. Synergy between PKA and CaMKII, including effects on
inhibitor-1, facilitates full responses to b-adrenergic
stimulation.
5. CaMKII is responsible for early adaptation of FDAR via
LCC phosphorylation.
6. CaMKII modulates ECC gain, though this influence is
highly dependent on SR Ca2þ.
7. CaMKII hyperphosphorylation of RyRs is arrhythmo-
genic and further potentiated by adrenergic stimulation.CaMKII substrate phosphorylation and regulation
of Ca2þ handling
While there is limited kinetic data regarding CaMKII
phosphorylation at the modeled targets, our quantitative
steady-state levels are generally consistent with available
experimental measurements (see the Supporting Material)
(20,21). At the LCC, we assumed quick kinetics to mimic
rapid CaMKII-dependent ICa facilitation (13,15,16). As sug-
gested by a number of experiments (21,29), we predicted
slower kinetics at PLB that resulted in quantitatively small
phosphorylation levels. While we predicted somewhat
slow RyR kinetics, some data suggests that CaMKII-depen-
dent RyR phosphorylation occurs on the order of ~3 min
(21). Such slow kinetics are difficult to reconcile with the
much faster functional consequences of ICa facilitation
(13,15,16), given that RyRs are concentrated near LCCs in
dyads. Further experimental work is needed to clarify these
issues. Also, data regarding CaMKII-dependent RyR regu-
lation is somewhat conflicting (36,37), though our results
indicate that positive regulation is critical for predictions
of reduced SR Ca2þ content and enhanced leak during
CaMKII-OE (as in experiments (11)).
Our model reproduced a range of data from rabbit
myocytes acutely overexpressing CaMKII, including Ca2þ
transient amplitudes, [Ca2þ]SRT, fractional release, APD,
changes in [Na]i, postrest decay, and FDAR (8,25,26). In
transgenic mouse models, similar results are observed (in
terms of Ca2þ sparks and [Ca2þ]SRT) though these animals
show dramatically depressed Ca2þ transients and longer
APD. In addition to species differences, these myocytes
exhibit compensatory changes in protein expression
including decreased RyR, PLB, and SERCAwith increased
Naþ/Ca2þ exchanger, that are not observed in the rabbit
experiments. These alterations may partially explain
phenotypic differences between these animal models. Koi-
vuma¨ki et al. (38) recently modeled CaMKII-OE and found
that inclusion of these secondary expression changes was
critical for reproducing the mouse phenotype. Also, our
predicted changes in [Na]i are qualitatively similar but
smaller than the levels measured experimentally (25), sug-
gesting that CaMKII may regulate [Na]i through additional
mechanisms.
We predicted that CaMKII-KO decreases steady-state
D[Ca2þ]i and APD compared with control conditions. But
CaMKII Regulation of Ca Handling 2045in CaMKII-KO or CaMKII inhibited mice, D[Ca2þ]i is
normal (39,40), though secondary compensatory mecha-
nisms play a role in maintaining Ca2þ handling (40).
In Wagner et al. (26), the CaMKII inhibitor AIP somewhat
reduced APD in normal myocytes but reversed the AP short-
ening effect of CaMKII-OE. The subtle model-experiment
differences here may be due to partial CaMKII inhibition
by AIP but complete CaMKII elimination in our model.
We provided additional evidence for the role of CaMKII
in early FDAR and ECC gain. Several experiments have
indicated that FDAR adaptation and PLB-Thr17 phosphory-
lation are temporally dissimilar (21,29). Our model agrees
with these findings, where FDAR is rapid and PLB phos-
phorylation is slow and quantitatively small in control
scenarios. However, we found that CaMKII-KO slowed
FDAR and that LCC phosphorylation appeared to facilitate
this quick adaptation. In addition, CaMKII-OE made the
slope of steady-state FDAR more negative (consistent with
experiments (7)), while the converse was true for CaMKII-
KO. CaMKII inhibition either strongly inhibits (27),
partially inhibits (8), or fails to affect (29) steady-state
FDAR in experiments; our included mechanisms support
findings of only slight CaMKII-dependence on steady-state
FDAR. We also showed that the presence of CaMKII
enhances ECC gain, though gain was smaller during
CaMKII-OE. However, gain is highly SR-load-dependent
(10), so we tested our model in scenarios of matched SR
load. We found that CaMKII-OE dramatically enhanced
gain, while CaMKII-KO produced the opposite effect.
Thus, CaMKII can enhance gain, though this effect may
be masked in conditions of low SR Ca2þ.Role of CaMKII-Ca2þ-CaMKII feedback
The model predicted that the three dynamic CaMKII
substrates contribute to CaMKII-Ca2þ-CaMKII feedback,
though RyR phosphorylation was most prominent. CaMKII
activity was also enhanced in simulations with the b-adren-
ergic agonist ISO due to enhanced Ca2þ fluxes via PKA
phosphorylation. We found that CaMKII helped facilitate
overall b-adrenergic enhancement of Ca2þ transients via
synergy between PKA and CaMKII-dependent phosphory-
lation. Specifically, it appeared that PKA-dependent
increases in LCC and SERCA flux, combined with CaMKII-
dependent RyR fluxes, were a major source of crosstalk.
PKA activation of inhibitor-1, another route of crosstalk
between these pathways, substantially increased Thr17
PLB phosphorylation independent of enhanced Ca2þ
signals.
Interestingly, Curran et al. (19) found that the CaMKII
inhibitor KN-93 eliminated ISO-induced enhancement of
peak [Ca2þ]i in rabbit myocytes, in accordance with our
results. However, KN-93 can inhibit ICa in a CaMKII-
independent manner which complicates these findings
(41). In another study, transgenic mice expressing a CaMKIIinhibitor (AC3-I) produced full adrenergic responses,
though these results are complicated by secondary PKA-
dependent increases in ICa (40). Our results thus suggest
that, excluding secondary compensatory mechanisms, CaM-
KII can play a role in facilitating inotropic responses to
acute adrenergic stimulation.Arrhythmogenesis
Hyperactive CaMKII is suspected to be proarrhythmogenic,
due mainly to its ability to enhance LCC gating and RyR
sensitivity (5,30). We found that CaMKII-OE þ ISO
with R2 Hz pacing or CaMKII-OE alone with R3 Hz
pacing produced DADs after abrupt stimulus removal. Use
of a well-validated model of the RyR (in terms of open prob-
ability, leak, fractional release, and response to agonists
(e.g., caffeine)) and a Naþ/Ca2þ exchanger model that
responds to subsarcolemmal Ca2þ signals was critical for
our analysis (10). Our model demonstrates that CaMKII-
dependent increases in RyR Ca2þ sensitivity and leak can
lower the threshold for spontaneous SR Ca2þ release, while
ISO-induced enhancement of [Ca2þ]SRT can potentiate these
effects. We also showed that the threshold amount of Ca2þ
release required to trigger a full DAD is consistent with
experimental measurements (31). In our simulations, elimi-
nation of CaMKII’s ability to hyperphosphorylate the RyR
(i.e., fixing phosphorylation to control levels) eliminated
DADs, with less influence from PKA-dependent RyR phos-
phorylation. Sag et al. (42) demonstrated that b-adrenergic
stimulation of CaMKII-OE mouse myocytes increased the
number of DADs, consistent with our model predictions.
While DADs involve the complex interplay of several mech-
anisms, the model illustrates a quantitatively significant
contribution from CaMKII-dependent hyperphosphoryla-
tion of RyRs.
While early after-depolarizations (EADs) have been
linked to abnormal CaMKII signaling (5,6,42), EADs
were not observed in our model, even during adrenergic
stimulation. CaMKII is believed to induce EADs through
its interactions with LCCs (5). Though LCC-mediated
EADs can be generated using deterministic computational
models (43), the CaMKII-dependent LCC alterations
included here, with and without adrenergic stimulation,
were insufficient. Stochastic models of LCC modal gating
can trigger EADs (44), which may suggest that EAD forma-
tion via CaMKII is sensitive to stochasticity. CaMKII-RyR
interactions may also be sensitive to stochasticity. Also,
the mechanism of DAD formation could be sensitive to
model formulation (e.g., a single dyad versus multiple, inde-
pendent dyads). Given that our CaMKII-RyR model is suffi-
cient to predict global changes in [Ca2þ]SRT and SR leak
seen experimentally and the much larger computational
burden for stochastic simulations, our deterministic model
appears to be an appropriate first step for analyzing changes
in Ca2þ handling that may lead to arrhythmia.Biophysical Journal 99(7) 2038–2047
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While we were careful to focus on well-validated interac-
tions constrained by quantitative measurements, uncer-
tainties in the exact mechanisms underlying the functional
consequences of these interactions are unavoidable. In our
CaMKII model, basal kinase activity is low (<1%) due to
limited Ca2þ/CaM binding at diastolic Ca2þ levels and
high [PP1] in the dyadic cleft. However, increased Ca2þ
spark frequency during CaMKII-OE indirectly suggests
that CaMKII is partially active during rest (7,8,45). This
discrepancy could be due to a change in the balance of
kinase and phosphatase activities (3), but additional experi-
mental data and analysis are needed.
While we included several CaMKII activation mecha-
nisms (e.g., Ca2þ/CaM-dependent, autonomous, ECC feed-
back, and ISO), there are still other Ca2þ-independent
mechanisms that control CaMKII activity. Erickson et al.
(46) demonstrated that CaMKII can be oxidized at methio-
nine residues (281/282), conferring additional memory to
CaMKII. Christensen et al. (47) modeled CaMKII oxida-
tion, showing increased activity in infarct border zones
that was predicted to reduce conduction velocity and
increase susceptibility to conduction block. CaMKII can
also autophosphorylate at Thr306 after Thr287 phosphoryla-
tion, but Thr287 autophosphorylation is not prominent in
our simulations. In addition, CaMKII can be activated
during b1-specific adrenergic stimulation via formation of
a b-arrestin-CaMKII-Epac1 complex, which may confer
additional signaling potential to CaMKII during adrenergic
stimulation (48). These additional activation mechanisms
may be examined in subsequent studies.SUPPORTING MATERIAL
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